Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?

Matthew Strohl, Lorant Gonczi, Zsuzsanna Kurt, Talat Bessissow, P. Lakatos

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Inflammatory bowel disease (IBD) is a lifelong, progressive disease that has disabling impacts on patient's lives. Given the complex nature of the diagnosis of IBD and its management there is consequently a large economic burden seen across all health care systems. Quality indicators (QI) have been created to assess the different façades of disease management including structure, process and outcome components. Their development serves to provide a means to target and measure quality of care (QoC). Multiple different QI sets have been published in IBD, but all serve the same purpose of trying to achieve a standard of care that can be attained on a national and international level, since there is still a major variation in clinical practice. There have been many recent innovative developments that aim to improve QoC in IBD including telemedicine, home biomarker assessment and rapid access clinics. These are some of the novel advancements that have been shown to have great potential at improving QoC, while offloading some of the burden that IBD can have vis-a-vis emergency room visits and hospital admissions. The aim of the current review is to summarize and discuss available QI sets and recent developments in IBD care including telemedicine, and to give insight into how the utilization of these tools could benefit the QoC of IBD patients. Additionally, a treatingto- target structure as well as evidence surrounding aggressive management directed at tighter disease control will be presented.

Original languageEnglish
Pages (from-to)2363-2372
Number of pages10
JournalWorld journal of gastroenterology
Volume24
Issue number22
DOIs
Publication statusPublished - Jun 14 2018

Fingerprint

Quality of Health Care
Inflammatory Bowel Diseases
Telemedicine
Disease Management
Standard of Care
Hospital Emergency Service
Biomarkers
Economics
Delivery of Health Care

Keywords

  • Inflammatory bowel disease
  • Quality indicators
  • Quality of care
  • Telemedicine
  • Treat-to-target

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Quality of care in inflammatory bowel diseases : What is the best way to better outcomes? / Strohl, Matthew; Gonczi, Lorant; Kurt, Zsuzsanna; Bessissow, Talat; Lakatos, P.

In: World journal of gastroenterology, Vol. 24, No. 22, 14.06.2018, p. 2363-2372.

Research output: Contribution to journalReview article

Strohl, Matthew ; Gonczi, Lorant ; Kurt, Zsuzsanna ; Bessissow, Talat ; Lakatos, P. / Quality of care in inflammatory bowel diseases : What is the best way to better outcomes?. In: World journal of gastroenterology. 2018 ; Vol. 24, No. 22. pp. 2363-2372.
@article{6c49cf90fa2d48068b921d6f81497b26,
title = "Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?",
abstract = "Inflammatory bowel disease (IBD) is a lifelong, progressive disease that has disabling impacts on patient's lives. Given the complex nature of the diagnosis of IBD and its management there is consequently a large economic burden seen across all health care systems. Quality indicators (QI) have been created to assess the different fa{\cc}ades of disease management including structure, process and outcome components. Their development serves to provide a means to target and measure quality of care (QoC). Multiple different QI sets have been published in IBD, but all serve the same purpose of trying to achieve a standard of care that can be attained on a national and international level, since there is still a major variation in clinical practice. There have been many recent innovative developments that aim to improve QoC in IBD including telemedicine, home biomarker assessment and rapid access clinics. These are some of the novel advancements that have been shown to have great potential at improving QoC, while offloading some of the burden that IBD can have vis-a-vis emergency room visits and hospital admissions. The aim of the current review is to summarize and discuss available QI sets and recent developments in IBD care including telemedicine, and to give insight into how the utilization of these tools could benefit the QoC of IBD patients. Additionally, a treatingto- target structure as well as evidence surrounding aggressive management directed at tighter disease control will be presented.",
keywords = "Inflammatory bowel disease, Quality indicators, Quality of care, Telemedicine, Treat-to-target",
author = "Matthew Strohl and Lorant Gonczi and Zsuzsanna Kurt and Talat Bessissow and P. Lakatos",
year = "2018",
month = "6",
day = "14",
doi = "10.3748/wjg.v24.i22.2363",
language = "English",
volume = "24",
pages = "2363--2372",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "22",

}

TY - JOUR

T1 - Quality of care in inflammatory bowel diseases

T2 - What is the best way to better outcomes?

AU - Strohl, Matthew

AU - Gonczi, Lorant

AU - Kurt, Zsuzsanna

AU - Bessissow, Talat

AU - Lakatos, P.

PY - 2018/6/14

Y1 - 2018/6/14

N2 - Inflammatory bowel disease (IBD) is a lifelong, progressive disease that has disabling impacts on patient's lives. Given the complex nature of the diagnosis of IBD and its management there is consequently a large economic burden seen across all health care systems. Quality indicators (QI) have been created to assess the different façades of disease management including structure, process and outcome components. Their development serves to provide a means to target and measure quality of care (QoC). Multiple different QI sets have been published in IBD, but all serve the same purpose of trying to achieve a standard of care that can be attained on a national and international level, since there is still a major variation in clinical practice. There have been many recent innovative developments that aim to improve QoC in IBD including telemedicine, home biomarker assessment and rapid access clinics. These are some of the novel advancements that have been shown to have great potential at improving QoC, while offloading some of the burden that IBD can have vis-a-vis emergency room visits and hospital admissions. The aim of the current review is to summarize and discuss available QI sets and recent developments in IBD care including telemedicine, and to give insight into how the utilization of these tools could benefit the QoC of IBD patients. Additionally, a treatingto- target structure as well as evidence surrounding aggressive management directed at tighter disease control will be presented.

AB - Inflammatory bowel disease (IBD) is a lifelong, progressive disease that has disabling impacts on patient's lives. Given the complex nature of the diagnosis of IBD and its management there is consequently a large economic burden seen across all health care systems. Quality indicators (QI) have been created to assess the different façades of disease management including structure, process and outcome components. Their development serves to provide a means to target and measure quality of care (QoC). Multiple different QI sets have been published in IBD, but all serve the same purpose of trying to achieve a standard of care that can be attained on a national and international level, since there is still a major variation in clinical practice. There have been many recent innovative developments that aim to improve QoC in IBD including telemedicine, home biomarker assessment and rapid access clinics. These are some of the novel advancements that have been shown to have great potential at improving QoC, while offloading some of the burden that IBD can have vis-a-vis emergency room visits and hospital admissions. The aim of the current review is to summarize and discuss available QI sets and recent developments in IBD care including telemedicine, and to give insight into how the utilization of these tools could benefit the QoC of IBD patients. Additionally, a treatingto- target structure as well as evidence surrounding aggressive management directed at tighter disease control will be presented.

KW - Inflammatory bowel disease

KW - Quality indicators

KW - Quality of care

KW - Telemedicine

KW - Treat-to-target

UR - http://www.scopus.com/inward/record.url?scp=85048841296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048841296&partnerID=8YFLogxK

U2 - 10.3748/wjg.v24.i22.2363

DO - 10.3748/wjg.v24.i22.2363

M3 - Review article

C2 - 29904243

AN - SCOPUS:85048841296

VL - 24

SP - 2363

EP - 2372

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 22

ER -